Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Perez, Marco, Lucena-Cacace, Antonio, Marín-Gómez, Luis Miguel, Padillo-Ruiz, Javier, Robles-Frias, Maria Jose, Saez, Carmen, Garcia-Carbonero, Rocio, Carnero, Amancio
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Correction
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363656/
https://ncbi.nlm.nih.gov/pubmed/28074043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13482
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items